Back

Estrogen receptor alpha regulates alcohol craving in females: convergent evidence from mouse models and human genetics

Pagano, R.; Kruashvili, L.; Puchalska, M.; Kalinichenko, L. S.; Rizwan, Y.; Swiderska, J.; Wojtas, B.; Gielniewski, B.; Choleris, E.; Samochowiec, J.; Awasthi, S.; Bach, P.; Frank, J.; Heinz, A.; Hoffmann, S.; Ripke, S.; Smolka, M.; Witt, S. H.; Muhle, C.; Kornhuber, J.; Kiefer, F.; Muller, C. P.; Lenz, B.; Radwanska, K.

2026-06-08 neuroscience
10.64898/2026.06.03.729849 bioRxiv
Show abstract

Alcohol craving and consumption fluctuate across the reproductive cycle in females with alcohol use disorder (AUD), suggesting that estrogen signaling contributes to disease vulnerability. Here, we investigated the role of estrogen receptor alpha (ER; Esr1; ESR1) in alcohol seeking using complementary mouse and human approaches, as this receptor was previously identified as a risk factor for AUD. Female mice were characterized in an IntelliCage-based multidimensional AUD paradigm that stratifies individuals into AUD-prone and AUD-resistant phenotypes. Transcriptomic profiling of the amygdala revealed that Esr1 is a top transcription factor for differentially expressed genes in mice drinking alcohol, and the estrogen signaling pathway was deregulated specifically in AUD-prone mice. Although alcohol exposure did not alter overall Esr1/ER mRNA or protein abundance, both transcript and protein levels positively correlated with cue-induced alcohol seeking, indicating that inter-individual variation in ER signaling predicts relapse-like behavior. Causal manipulations confirmed a functional role of ER. Local knockdown of Esr1 in the basolateral amygdala reduced excitatory synaptic transmission, attenuated alcohol motivation, cue-induced seeking, and relapse drinking, and impaired cue-associated memory recall without affecting anxiety-like behavior. Similarly, ovariectomy decreased amygdala ER expression, altered synaptic protein markers, and reduced alcohol-seeking behaviors, supporting regulation by endogenous ovarian hormones. Extending these findings to humans, ESR1 gene polymorphisms (rs6902771, rs11155819 and rs6557171) were associated with the probability of alcohol binge drinking and alcohol consumption days as well as craving and loss of control in real world in a longitudinal clinical cohort, while ESR1 mRNA blood levels were increased in women with AUD diagnosis. Together, these convergent molecular, circuit, behavioral, and genetic data identify ER signaling in the amygdala as an important modulator of alcohol-seeking behavior induced by alcohol cue and relapse vulnerability, highlighting estrogen pathways as potential therapeutic targets and markers for AUD.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Alcohol, Clinical and Experimental Research
14 papers in training set
Top 0.1%
11.9%
2
Neuropharmacology
68 papers in training set
Top 0.1%
11.9%
3
Neuropsychopharmacology
153 papers in training set
Top 0.4%
7.8%
4
Alcohol
18 papers in training set
Top 0.1%
7.8%
5
Addiction Biology
51 papers in training set
Top 0.1%
6.7%
6
Molecular Psychiatry
282 papers in training set
Top 1%
5.5%
50% of probability mass above
7
The Journal of Neuroscience
1025 papers in training set
Top 3%
5.5%
8
Alcoholism: Clinical and Experimental Research
14 papers in training set
Top 0.1%
4.4%
9
Translational Psychiatry
260 papers in training set
Top 1%
4.4%
10
American Journal of Psychiatry
24 papers in training set
Top 0.1%
3.4%
11
Biological Psychiatry Global Open Science
60 papers in training set
Top 0.3%
3.2%
12
Biological Psychiatry
137 papers in training set
Top 1%
2.1%
13
Psychopharmacology
69 papers in training set
Top 0.4%
2.1%
14
eLife
5828 papers in training set
Top 44%
2.1%
15
eneuro
439 papers in training set
Top 4%
1.9%
16
Nature Communications
5641 papers in training set
Top 43%
1.9%
17
Addiction Neuroscience
17 papers in training set
Top 0.2%
1.3%
18
Scientific Reports
3612 papers in training set
Top 65%
1.1%
19
Psychological Medicine
88 papers in training set
Top 2%
0.8%
20
Science Advances
1243 papers in training set
Top 33%
0.6%
21
Frontiers in Behavioral Neuroscience
49 papers in training set
Top 1%
0.6%
22
PLOS ONE
5266 papers in training set
Top 65%
0.6%
23
European Neuropsychopharmacology
20 papers in training set
Top 0.6%
0.6%
24
Neurobiology of Disease
148 papers in training set
Top 4%
0.6%